IDEAS home Printed from https://ideas.repec.org/r/oup/indcch/v18y2009i4p729-759.html
   My bibliography  Save this item

Experimentation with strategy and the evolution of dynamic capability in the Indian pharmaceutical sector

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Lopez-Vega, Henry & Tell, Fredrik, 2021. "Technology strategy and MNE subsidiary upgrading in emerging markets," Technological Forecasting and Social Change, Elsevier, vol. 167(C).
  2. Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
  3. Basant, Rakesh, 2010. "Intellectual Property Protection, Regulation and Innovation in Developing Economies - The Case of Indian Pharmaceutical Industry," IIMA Working Papers WP2010-11-02, Indian Institute of Management Ahmedabad, Research and Publication Department.
  4. Ching T. Liao, 2022. "Skill improvement by product imitation," Small Business Economics, Springer, vol. 58(3), pages 1563-1577, March.
  5. Vivekananda Mukherjee & Shyama Ramani, 2011. "R&D cooperation in emerging industries, asymmetric innovative capabilities and rationale for technology parks," Theory and Decision, Springer, vol. 71(3), pages 373-394, September.
  6. Athreye, Suma & Godley, Andrew, 2008. "Internationalising to create Firm Specific Advantages: Leapfrogging strategies of U.S. Pharmaceutical firms in the 1930s and 1940s & Indian Pharmaceutical firms in the 1990s and 2000s," MERIT Working Papers 2008-051, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  7. Bukhvalov, A. & Alekseeva, O., 2016. "International joint venture acquisition by a foreign or local partner," Working Papers 6439, Graduate School of Management, St. Petersburg State University.
  8. Guennif, Samira & Ramani, Shyama V., 2012. "Explaining divergence in catching-up in pharma between India and Brazil using the NSI framework," Research Policy, Elsevier, vol. 41(2), pages 430-441.
  9. Kale, Dinar, 2019. "From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry," Technological Forecasting and Social Change, Elsevier, vol. 145(C), pages 370-383.
  10. Ramani, Shyama V. & Urias, Eduardo, 2018. "When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil," Research Policy, Elsevier, vol. 47(8), pages 1538-1552.
  11. Pradeep Kanta Ray & Sangeeta Ray & Vikas Kumar, 2017. "Internationalization of latecomer firms from emerging economies—The role of resultant and autonomous learning," Asia Pacific Journal of Management, Springer, vol. 34(4), pages 851-873, December.
  12. Guennif, Samir & Ramani, Shyama, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," MERIT Working Papers 2010-019, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  13. Angelo Kenneth S. Romasanta & Peter Sijde & Jacqueline Muijlwijk-Koezen, 2020. "Innovation in pharmaceutical R&D: mapping the research landscape," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(3), pages 1801-1832, December.
  14. Rory Horner, 2022. "Global value chains, import orientation, and the state: South Africa’s pharmaceutical industry," Journal of International Business Policy, Palgrave Macmillan, vol. 5(1), pages 68-87, March.
  15. David E. Hojman, 2016. "Getting Innovation Right: The Key to Happiness and Flourishing?," Homo Oeconomicus: Journal of Behavioral and Institutional Economics, Springer, vol. 33(4), pages 311-316, December.
  16. Munjal, Surender & Andersson, Ulf & Pereira, Vijay & Budhwar, Pawan, 2021. "Exploring reverse knowledge transfer and asset augmentation strategy by developed country MNEs: Case study evidence from the Indian pharmaceutical industry," International Business Review, Elsevier, vol. 30(6).
  17. Dinesh Abrol & Pramod Prajapati & Nidhi Singh, 2011. "Globalization of the Indian Pharmaceutical Industry: Implications for Innovation," Institutions and Economies (formerly known as International Journal of Institutions and Economies), Faculty of Economics and Administration, University of Malaya, vol. 3(2), pages 327-365, July.
  18. Rakesh Basant, 2010. "Intellectual Property Protection, Regulation and Innovation in Developing Economies: The Case of Indian Pharmaceutical Industry," Working Papers id:3208, eSocialSciences.
  19. Shyama V. Ramani & Samira Guennif, 2012. "Catching up in the Pharmaceutical Sector: Lessons from Case Studies of India and Brazil," Chapters, in: Franco Malerba & Richard R. Nelson (ed.), Economic Development as a Learning Process, chapter 5, Edward Elgar Publishing.
  20. Eriksson, Taina, 2014. "Processes, antecedents and outcomes of dynamic capabilities," Scandinavian Journal of Management, Elsevier, vol. 30(1), pages 65-82.
  21. Hafsi, Taïeb & Hu, Hao, 2016. "Sectoral innovation through competing logics: The case of antidepressants in traditional Chinese medicine," Technological Forecasting and Social Change, Elsevier, vol. 107(C), pages 80-89.
  22. Thakur–Wernz, Pooja & Wernz, Christian, 2022. "Impact of stronger intellectual property rights regime on innovation: Evidence from de alio versus de novo Indian bio-pharmaceutical firms," Journal of Business Research, Elsevier, vol. 138(C), pages 457-473.
  23. Bhawani Bhatnagar & Viktor Dörfler & Jillian MacBryde, 2023. "Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries," The Journal of Technology Transfer, Springer, vol. 48(6), pages 2204-2248, December.
  24. Mahendra Kumar Pallapothu & Gary Evans, 2013. "Gauging the Market and Non-Market Forces in Indian Aquaculture Industry for a Strategic Position in Fish Vaccines Market," Journal of Management and Strategy, Journal of Management and Strategy, Sciedu Press, vol. 4(1), pages 41-61, February.
  25. Mukherjee, Vivekananda & Ramani, Shyama V., 2008. "R&D cooperation, asymmetric technological capabilities and rationale for technology parks," Dresden Discussion Paper Series in Economics 11/08, Technische Universität Dresden, Faculty of Business and Economics, Department of Economics.
  26. Samira Guennif & Shyama V. Ramani, 2010. "Catching up in pharmaceuticals: a comparative study of India and Brazil," Working Papers hal-00632439, HAL.
  27. Ray, Sangeeta & Ray, Pradeep Kanta, 2021. "Innovation strategy of latecomer firms under tight appropriability regimes: The Indian pharmaceuticals industry," Journal of International Management, Elsevier, vol. 27(1).
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.